Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 12-2019 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 0 | 4,533,000 | 4,275,000 |
| Marketable Securities | N/A | 0 | 0 | 1,665,000 | 1,657,000 |
| Receivables | N/A | 0 | 0 | 1,941,000 | 1,828,000 |
| Inventories | N/A | 0 | 0 | 1,299,000 | 1,408,000 |
| Income taxes - deferred | N/A | N/A | N/A | 500,000 | 395,000 |
| Other current assets | 0 | 0 | 0 | 0 | 34,000 |
| TOTAL | $N/A | $0 | $0 | $10,073,000 | $9,691,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 5,404,000 | 5,320,000 |
| Investments And Advances | 0 | 0 | 0 | 3,347,000 | 2,606,000 |
| Intangibles | 0 | 0 | 0 | 2,598,000 | 2,636,000 |
| Other Non-Current Assets | 0 | 0 | 0 | 365,000 | 358,000 |
| TOTAL | $N/A | $N/A | $N/A | $11,714,000 | $10,920,000 |
| Total Assets | $N/A | $0 | $0 | $21,787,000 | $20,611,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 228,000 | 235,000 |
| TOTAL | $N/A | $0 | $0 | $3,095,000 | $2,836,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | 2,329,000 | 2,504,000 |
| Deferred Revenues | N/A | N/A | N/A | 88,000 | 81,000 |
| Other Non-Current Liabilities | 0 | 71 | 0 | 248,000 | 248,000 |
| TOTAL | $N/A | $N/A | $N/A | $3,021,000 | $3,149,000 |
| Total Liabilities | $N/A | $0 | $0 | $6,116,000 | $5,985,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 1,053,414 | 1,052,034 |
| Common Shares | N/A | 0 | 0 | 21,000 | 21,000 |
| Retained earnings | N/A | 0 | 0 | 3,482,000 | 2,571,000 |
| Other shareholders' equity | 0 | 0 | 0 | 124,000 | 137,000 |
| TOTAL | $N/A | $0 | $0 | $15,671,000 | $14,626,000 |
| Total Liabilities And Equity | $0 | $0 | $0 | $21,787,000 | $20,611,000 |